Roundtable Discussion: Integrating Radiopharmacies into the Radiotherapy Manufacturing Ecosystem to Expand Reach, Reduce Strain, & Accelerate Patient Access
- Exploring how leveraging radiopharmacies for therapeutic preparation can extend regional coverage, reduce time-to-treatment for short-lived isotopes, and ease pressure on centralized manufacturing
- Understanding regulatory and operational restrictions in compounding manufacturing and radiopharmacy roles
- Discussing strategic partnerships with national pharmacy networks to improve batch consistency, point-of-care readiness, and public/physician trust in decentralized delivery